Loading viewer...
investor_presentation
Format: PDF investor_presentation
Chr. Hansen is a microbial biotech company with leading market positions across human health, animal health, and plant health. The company generates 66% of revenue from food cultures and enzymes, with the remaining 34% from health and nutrition products including probiotics, bio-protection, and fermented plant bases.
investor_presentation
21 Pages
AIB Group Plc
investor_presentation
Ternium